Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
ListGraphMap
Displaying 1 - 10 of 17 Projects
Project # Contact PI Funding Organization Fiscal Year
Assessing poly(GP) proteins as clinical and pharmacodynamic biomarkers of C9ORF72-associated FTD
2019-005 PETRUCELLI, LEONARD The Association for Frontotemporal Degeneration 2019
Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders
GC-201712-2014401 Upton, Meredith Alzheimer's Drug Discovery Foundation 2018
Rescue of lysosomal dysfunction, neuroinflammation, and neurodegeneration by lysosomal GRN-2 in a mouse model of PGRN deficiency and frontotemporal dementia
AFTD-Kukar-2017 Kukar, Thomas The Association for Frontotemporal Degeneration 2017
Assessing polyGP proteins as clinical and pharmacodynamic biomarkers of C9ORF72-associated FTD
AFTD-Petrucelli-2017 PETRUCELLI, LEONARD The Association for Frontotemporal Degeneration 2017
Identification of novel biofluid markers of tau and TDP-43 pathology
AFTD-Rohrer-2017 Rohrer, Jonathan The Association for Frontotemporal Degeneration 2017
Using TDP43 as a biomarker in FTD patients
AFTD-Steen-2017 Steen, Judith The Association for Frontotemporal Degeneration 2017
Mitochondrial TDP-43 as a Novel Therapeutic Target for FTD
AFTD-Wang-2016 WANG, XINGLONG The Association for Frontotemporal Degeneration 2016
FTD Trafficking Assays and Compound Screening: Inhibiting Sortilin-dependent progranulin endocytosis.
20141106-Sneddon-2014 Sneddon, Scott Alzheimer's Drug Discovery Foundation 2014
FTD C9ORF72 Based Biomarkers for Antisense-based Drug Discovery Validation
AFTD-Rothstein-2013 Rothstein, Jeffrey The Association for Frontotemporal Degeneration 2013
Validation of a Novel Target Mechanism to Counter Progresion of Alzheimer's Disease
2011383 20121101-Wennogle-2012 Wennogle, Lawrence Alzheimer's Drug Discovery Foundation 2012